AR207462A1 - Procedimiento para preparar 7-(oxoalquil)-1,3-dialquilxantinas - Google Patents

Procedimiento para preparar 7-(oxoalquil)-1,3-dialquilxantinas

Info

Publication number
AR207462A1
AR207462A1 AR257365A AR25736575A AR207462A1 AR 207462 A1 AR207462 A1 AR 207462A1 AR 257365 A AR257365 A AR 257365A AR 25736575 A AR25736575 A AR 25736575A AR 207462 A1 AR207462 A1 AR 207462A1
Authority
AR
Argentina
Prior art keywords
dialkylxanthines
oxoalkyl
preparing
procedure
Prior art date
Application number
AR257365A
Other languages
English (en)
Spanish (es)
Original Assignee
Wuelfing J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2402908A external-priority patent/DE2402908C2/de
Application filed by Wuelfing J filed Critical Wuelfing J
Application granted granted Critical
Publication of AR207462A1 publication Critical patent/AR207462A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR257365A 1974-01-22 1975-01-01 Procedimiento para preparar 7-(oxoalquil)-1,3-dialquilxantinas AR207462A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2402908A DE2402908C2 (de) 1974-01-22 1974-01-22 7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
AR207462A1 true AR207462A1 (es) 1976-10-08

Family

ID=5905372

Family Applications (1)

Application Number Title Priority Date Filing Date
AR257365A AR207462A1 (es) 1974-01-22 1975-01-01 Procedimiento para preparar 7-(oxoalquil)-1,3-dialquilxantinas

Country Status (13)

Country Link
US (2) US4242345A (de)
JP (1) JPS5912677B2 (de)
AR (1) AR207462A1 (de)
AT (1) AT338286B (de)
BE (1) BE824665A (de)
CA (1) CA1068693A (de)
CH (1) CH608236A5 (de)
FI (1) FI59596C (de)
FR (1) FR2258183B1 (de)
GB (1) GB1441562A (de)
HU (1) HU169012B (de)
NL (1) NL184330C (de)
YU (1) YU15175A (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
DE3173289D1 (en) * 1980-06-21 1986-02-06 Beecham Wuelfing Gmbh & Co Kg Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DK0484785T3 (da) * 1990-11-07 1996-09-23 Hoechst Marion Roussel Inc Anvendelse af xanthiner til fremstilling af et lægemiddel, der er virksomt til inhibering af formeringen af humane retrovira
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
DE59304710D1 (de) * 1992-02-22 1997-01-23 Hoechst Ag Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US6322771B1 (en) 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
US6670334B2 (en) 2001-01-05 2003-12-30 University Of Virginia Patent Foundation Method and compositions for treating the inflammatory response
AU2002362443B2 (en) * 2001-10-01 2008-05-15 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
US7442687B2 (en) * 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
WO2006028618A1 (en) * 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
EP2266994B1 (de) * 2004-08-02 2013-04-03 University Of Virginia Patent Foundation 2-propynyl-adenosin-Analoga mit modifizierten 5'-Ribosegruppen mit A2A-Agonistenaktivität
US8178509B2 (en) * 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756229A (en) * 1956-07-24 Xanthine derivatives
US2761863A (en) * 1956-09-04 Lower-alkyl
CA557342A (en) 1958-05-13 Doebel Karl Process for the manufacture of novel xanthine derivatives
FR4791E (fr) 1900-06-29 1905-10-16 Eugene Fournier Lampe à pétrole perfectionnée pour chauffage intensif dite: "la naphteuse"
DE926788C (de) 1952-11-07 1955-04-25 Geigy Ag J R Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen
GB759174A (en) * 1952-11-07 1956-10-17 Geigy Ag J R Improvements in diuretic acting xanthine derivatives
GB759981A (en) * 1953-09-09 1956-10-24 Roche Products Ltd Process for the manufacture of xanthine derivatives
CH325292A (de) 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
DE2234202A1 (de) 1972-07-12 1974-01-24 Albert Ag Chem Werke Verfahren zur herstellung von oxoalkylxanthinen
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2457666A1 (de) * 1974-12-06 1976-06-10 Hoechst Ag Arzneimittel, verfahren zur herstellung von dafuer geeigneten wirkstoffen und diese oxoalkyl-dialkyl-xanthine
JPS5233120A (en) * 1975-09-10 1977-03-14 Nisshin Steel Co Ltd Double coiled automobile steel pipe covered with heat flexible plastic resin

Also Published As

Publication number Publication date
US4242345A (en) 1980-12-30
NL7414887A (nl) 1975-07-24
YU15175A (en) 1982-06-30
BE824665A (fr) 1975-05-15
JPS50101386A (de) 1975-08-11
AT338286B (de) 1977-08-10
GB1441562A (en) 1976-07-07
FI59596B (fi) 1981-05-29
FR2258183A1 (de) 1975-08-18
NL184330C (nl) 1989-06-16
FI750122A (de) 1975-07-23
JPS5912677B2 (ja) 1984-03-24
CA1068693A (en) 1979-12-25
US4291037A (en) 1981-09-22
CH608236A5 (de) 1978-12-29
FR2258183B1 (de) 1978-07-28
FI59596C (fi) 1981-09-10
HU169012B (de) 1976-08-28
ATA929674A (de) 1976-12-15
NL184330B (nl) 1989-01-16

Similar Documents

Publication Publication Date Title
AR207462A1 (es) Procedimiento para preparar 7-(oxoalquil)-1,3-dialquilxantinas
AR205578A1 (es) Procedimiento para preparar compuesto de 3-fenoxi-3-fenilpropilamina
MX5129E (es) Procedimiento para preparar alquiloximas derivadas del acido-7-amino-tiazolil-acetamido-cefalosporanico
MX4502E (es) Procedimiento para preparar 9alfa-hidroxiandrostenodiona
MX4047E (es) Procedimiento para preparar aralquilimidazoles
AR206908A1 (es) Procedimiento mejorado para preparar derivados 1-aciloxicarbonilicos
AR206937A1 (es) Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina
SE421919B (sv) Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner
MX3638E (es) Procedimiento para preparar metilpirazolilamidas
MX3837E (es) Procedimiento para preparar urea-amoniaco
AR216438A1 (es) Procedimiento para preparar derivados de difenil-alquil-aza-bicicloalcano
AR211013A1 (es) Procedimiento para preparar sderivados de rifamicina.
AR207582A1 (es) Procedimiento para preparar derivados de diaminociclitole
MX3832E (es) Procedimiento para preparar pirazolinonas
AR201414A1 (es) Procedimiento para preparar nueevos derivados amidoximicos
AR201506A1 (es) Procedimiento para preparar derivados de 4-hidroxi-3-nitrocarboestirilo
AR214273A1 (es) Procedimiento para preparar fenoxialquilalcanodionas
DOP1980002934A (es) Procedimiento para la obtencion de derivados de triazol
AR218216A1 (es) Procedimiento para preparar derivados de 4-amino-bencen-1,3-disulfonamidas-6-sustituidas
AR203639A1 (es) Procedimiento para preparar derivados de n-fenil-n-aminoalquil-2-amino-indano
AR207467A1 (es) Procedimiento para preparar derivados acetoximicos
AR206527A1 (es) Procedimiento para preparar cefalexinato de benzatina
AR213107A1 (es) Procedimiento para preparar derivados 1-alquil-3-nitropirazolicos
AR209966A1 (es) Procedimiento para preparar co-lest-5-enos 3-oxigenados 6-aminometilados
MX3627E (es) Procedimiento para preparar gamma-pironas